DR davis research investigating the roles of the novel diabetes gene, TCF19 through the use of knockout mice that lack expression of TCF19 use of normal mouse pancreatic islet tissue to understand how…
Ended Definitive Contract Awarded Last action
- Contract number
- 36C25220C0051
- Awardee
-
University Of Wisconsin System UEI CS5DGASZDJM3 Part of University Of Wisconsin System
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $149,194
Award facts
- Contract value 65% obligated
-
- $149,194.03 Current, with exercised options
- $228,434.03 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53706, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,541 | |
| Close Out | $0 | |
| Funding Only Action | -$2,104 | |
| Funding Only Action | $7,528 | |
| Exercise an Option | $19,500 | |
| Exercise an Option | $17,472 | |
| Funding Only Action | $0 | |
| Exercise an Option | $39,620 | |
| Funding Only Action | -$10,520 | |
| Exercise an Option | $39,620 | |
| Original award | $39,620 |
Show all 11
About this award
The University of Wisconsin System was awarded a $228,434 firm fixed price definitive contract by the Department of Veterans Affairs on December 15, 2019, to conduct diabetes research investigating the roles of the novel diabetes gene TCF19. The research involves utilizing knockout mice that lack TCF19 expression and normal mouse pancreatic islet tissue to understand how TCF19 impacts pancreatic islet survival and growth. The contract will be performed in Madison, Wisconsin, with an ultimate completion date of February 28, 2026. No set-aside designation was applied to this award.
This research contract represents the Department of Veterans Affairs' investment in fundamental biomedical research to advance understanding of diabetes genetics and pancreatic function. As a 1862 land grant institution with substantial research capabilities, the University of Wisconsin System brings specialized expertise in biological research and animal models necessary to execute this scientific investigation. The contract supports the VA's broader mission to develop improved treatments and interventions for conditions affecting the veteran population, leveraging academic research infrastructure to address chronic disease management challenges.
Description
DR davis research investigating the roles of the novel diabetes gene, TCF19 through the use of knockout mice that lack expression of TCF19 use of normal mouse pancreatic islet tissue to understand how TCF19 impacts pancreatic islet survival agrowth
Quick answers
Who was awarded contract 36C25220C0051?
36C25220C0051 was awarded to University Of Wisconsin System by Veterans Integrated Service Network 12 (Veterans Health Administration) on December 15, 2019.
How much is contract 36C25220C0051 worth?
The government has obligated $149,194 on 36C25220C0051. Its potential value, with all options, is $228,434.
Was contract 36C25220C0051 competed?
The extent of competition for 36C25220C0051 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award